Lilly and MiNA Therapeutics Announce saRNA Research Collaboration

INDIANAPOLIS and LONDON , May 11, 2021 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) and MiNA Therapeutics Limited , a pioneer in RNA activation therapeutics, today announced a global research collaboration to develop novel drug candidates using MiNA's proprietary small activating RNA (saRNA)